Search

everythinglearnresearchcommunity

for

Search:↓

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

AGA linked to worse COVID-19 outcomes in men.

Testosterone may influence COVID-19 severity and outcomes.

Men with severe balding have a higher risk of getting very sick from COVID-19.

Women with high androgen levels may have more severe COVID-19 symptoms.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

COVID-19 doesn't make alopecia areata worse.

Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.